Concepedia

Hans‐Michael Jantzen

HJ

Statistics

Publications

13

Citations

4.2K

H-Index

12

Active since

1979

Affiliations

Howard Hughes Medical Institute(Current)

VIR Biotechnology (United States)

Rapt Therapeutics (United States)

Massachusetts Institute of Technology

Hans‐Michael Jantzen is an author at Howard Hughes Medical Institute specializing in molecular biology, life sciences, and platelet aggregation.

Publications per year

1979–2001

13

Publications

13

Identification of the platelet ADP receptor targeted by antithrombotic drugs

Gunther Hollopeter, Hans‐Michael Jantzen, D Vincent et al. · Nature · 2001 · 1.4K citations

, , +14

Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene

Hans‐Michael Jantzen, Uwe Strähle, Bernd Gloss et al. · Cell · 1987 · 748 citations

, , +6

Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins

Hans‐Michael Jantzen, Arie Admon, Stephen P. Bell et al. · Nature · 1990 · 655 citations

, , +12

Functional Cooperativity Between Transcription Factors UBF1 and SL1 Mediates Human Ribosomal RNA Synthesis

Stephen P. Bell, R. Marc Learned, Hans‐Michael Jantzen et al. · Science · 1988 · 362 citations

, , +17

Assembly of alternative multiprotein complexes directs rRNA promoter selectivity.

Stephen P. Bell, Hans‐Michael Jantzen, Robert Tjian · Genes & Development · 1990 · 167 citations · Full text

, , +17

1–5 of 13